734 related articles for article (PubMed ID: 28266350)
1. Antimicrobial activity of a new synthetic peptide loaded in polylactic acid or poly(lactic-co-glycolic) acid nanoparticles against Pseudomonas aeruginosa, Escherichia coli O157:H7 and methicillin resistant Staphylococcus aureus (MRSA).
Cruz J; Flórez J; Torres R; Urquiza M; Gutiérrez JA; Guzmán F; Ortiz CC
Nanotechnology; 2017 Mar; 28(13):135102. PubMed ID: 28266350
[TBL] [Abstract][Full Text] [Related]
2. Design of Bactericidal Peptides Against Escherichia coli O157:H7, Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.
Cruz J; Rondon-Villarreal P; Torres RG; Urquiza M; Guzman F; Alvarez C; Abengozar MA; Sierra DA; Rivas L; Fernandez-Lafuente R; Ortiz CC
Med Chem; 2018; 14(7):741-752. PubMed ID: 29737262
[TBL] [Abstract][Full Text] [Related]
3. [Synthesis of antibiotic loaded polylactic acid nanoparticles and their antibacterial activity against Escherichia coli O157:H7 and methicillin-resistant Staphylococcus aureus].
Herrera MT; Artunduaga JJ; Ortiz CC; Torres RG
Biomedica; 2017 Jan; 37(1):11-21. PubMed ID: 28527243
[TBL] [Abstract][Full Text] [Related]
4. Potent and Specific Antibacterial Activity against
Gómez-Sequeda N; Ruiz J; Ortiz C; Urquiza M; Torres R
Antibiotics (Basel); 2020 Jul; 9(7):. PubMed ID: 32645834
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of antibacterial activity of caffeic acid phenethyl ester and PLGA nanoparticle formulation by different methods.
Arasoglu T; Derman S; Mansuroglu B
Nanotechnology; 2016 Jan; 27(2):025103. PubMed ID: 26629915
[TBL] [Abstract][Full Text] [Related]
6. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
7. Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates.
Shaaban MI; Shaker MA; Mady FM
J Nanobiotechnology; 2017 Apr; 15(1):29. PubMed ID: 28399890
[TBL] [Abstract][Full Text] [Related]
8. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
[TBL] [Abstract][Full Text] [Related]
9. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.
Ma W; Chen M; Kaushal S; McElroy M; Zhang Y; Ozkan C; Bouvet M; Kruse C; Grotjahn D; Ichim T; Minev B
Int J Nanomedicine; 2012; 7():1475-87. PubMed ID: 22619507
[TBL] [Abstract][Full Text] [Related]
10. A New Synthetic Peptide with In vitro Antibacterial Potential Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).
Prada YA; Guzmán F; Rondón P; Escobar P; Ortíz C; Sierra DA; Torres R; Mejía-Ospino E
Probiotics Antimicrob Proteins; 2016 Sep; 8(3):134-40. PubMed ID: 27301970
[TBL] [Abstract][Full Text] [Related]
11. Natural approach of using nisin and its nanoform as food bio-preservatives against methicillin resistant Staphylococcus aureus and E.coli O157:H7 in yoghurt.
Elsherif WM; Hassanien AA; Zayed GM; Kamal SM
BMC Vet Res; 2024 May; 20(1):192. PubMed ID: 38734600
[TBL] [Abstract][Full Text] [Related]
12. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
[TBL] [Abstract][Full Text] [Related]
13. New Synthetic Peptides Conjugated to Gold Nanoclusters: Antibiotic Activity Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).
Prada YA; Guzmán F; Ortíz C; Cabanzo R; Torres R; Mejía-Ospino E
Protein J; 2019 Oct; 38(5):506-514. PubMed ID: 31119600
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of 5-aminolevulinic acid (ALA) loaded PLGA nanoparticles.
Shi L; Wang X; Zhao F; Luan H; Tu Q; Huang Z; Wang H; Wang H
Int J Nanomedicine; 2013; 8():2669-76. PubMed ID: 23926429
[TBL] [Abstract][Full Text] [Related]
16. Formulation development and in vitro evaluation of gentamicin sulfate-loaded PLGA nanoparticles based film for the treatment of surgical site infection by Box-Behnken design.
Dhal C; Mishra R
Drug Dev Ind Pharm; 2019 May; 45(5):805-818. PubMed ID: 30698993
[TBL] [Abstract][Full Text] [Related]
17. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
Lee C; Seo J; Hwang HS; Thao LQ; Lee S; Lee ES; Lee EH; Choi HG; Youn YS
Biomed Pharmacother; 2016 Mar; 78():226-233. PubMed ID: 26898446
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic Analysis of Temperature-Dependent Curcumin Release from Poly(lactic-co-glycolic acid)/Poly(lactic acid) Polymer Nanoparticles.
Sunazuka Y; Ueda K; Higashi K; Wada K; Moribe K
Mol Pharm; 2024 Mar; 21(3):1424-1435. PubMed ID: 38324797
[TBL] [Abstract][Full Text] [Related]
19. Study of antimicrobial effects of vancomycin loaded PLGA nanoparticles against enterococcus clinical isolates.
Lotfipour F; Abdollahi S; Jelvehgari M; Valizadeh H; Hassan M; Milani M
Drug Res (Stuttg); 2014 Jul; 64(7):348-52. PubMed ID: 24307271
[TBL] [Abstract][Full Text] [Related]
20. In vitro degradation of poly (D, L-lactide-co-glycolide) nanoparticles loaded with linamarin.
Hussein AS; Abdullah N; Ahmadun FR
IET Nanobiotechnol; 2013 Jun; 7(2):33-41. PubMed ID: 24046903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
